GE Gets FDA Approval for Mobile X-Ray Systems
GE Healthcare has received FDA clearance of its Optima XR220amx, Optima XR200amx and Brivo XR285amx, a new platform of mobile x-ray systems.
GE Healthcare has received FDA clearance of its Optima XR220amx, Optima XR200amx and Brivo XR285amx, a new platform of mobile x-ray systems.
The product line responds to aging populations, rising obesity rates, and an increasing demand for patient-centric medical care by creating a “radiology room on wheels.”
The machines provide fast, low-dose images for diagnoses in challenging clinical settings.
The digital Optima XR220amx, digital-ready Optima XR200amx and Brivo XR285amx, are more compact and powerful than earlier models, featuring intuitive touch screens, immediate start-up capability, more storage and the high image quality required today.
The Optima XR220amx also immediately integrates with GE’s FlashPad digital wireless detector.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Expanded FDA Approval Allows Use of Pluvicto Prior to Chemotherapy in Patients with mCRPC
March 28th 2025Recent research demonstrated a 59 percent reduced risk of progression or death with the radioligand therapy Pluvicto in comparison to a change of androgen receptor pathway inhibitor (ARPI) for patients with metastatic castration-resistant prostate cancer (mCRPC).
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which will be unveiled at the American College of Cardiology (ACC) conference.
